Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
An Adaptive Design for Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 65 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests the best time to send messages that encourage older cancer survivors with long-term pain to be more active. It also tracks how often they have pain in the 24 hours after getting a message.
The purpose of this study is to assess the best time to deliver a message to increase physical activity and how often participants will experience a pain episode in the 24 hours following their receipt of a message to increase physical activity.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Age 65 or older.
- Have been diagnosed and treated for bladder, breast, cervical, colorectal (colon or rectum), endometrial (lining of the womb), lung, or prostate cancer.
- Speak and read English fluently.
- Have access to a smartphone.
- Can understand a written study consent form and are willing to sign it.
Who can't join
- Have cancer that has spread to distant parts of the body.
- Have cancer that has come back.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: 1. Age greater than or equal to 65 years. 2. Patients with a history of bladder, breast, cervical, colorectal, endometrial, lung, and prostate cancer diagnosis and treatment. 3. Fluent in spoken and written English. 4. Patient has access to smartphone 5. Ability to understand a written informed consent document, and the willingness to sign it. Exclusion Criteria: 1. Patient has metastatic disease. 2. Patient has cancer recurrence.
Study sites (1)
WI
- Froedtert Hospital · Milwaukee, WI 53226Kelly Clohesey Clinical Research Coordinator, MOT · Study contact · 414-801-6710 · kclohesey@mcw.eduWhitney Morelli, Assistant Professor, PhD · Principal investigatorMore trials in Milwaukee